Partners News Strategic partnership Enzyre BV and Takeda for better diagnostics for bleeding disorders
16 April 2021

Strategic partnership Enzyre BV and Takeda for better diagnostics for bleeding disorders

Takeda announced to have entered into a strategic partnership with Enzyre BV, a Radboudumc spin-off company. The partnership aims to accelerate the development of a diagnostic technology platform that improves the standard of care for patients with bleeding disorders.

Enzyre was founded in 2016 with the mission to save patients from bleeding to death with their Enzypad technology. Their vision is to create a point of care diagnostic platform that will measure a multitude of enzymatic reactions based on chemiluminescence.

Read the Takeda announcement here: https://lnkd.in/dJSqpRk

Related news items


Enzyre works towards cheaper care with integrated photonics

9 June 2022

Integrated photonics is a technology that will be decisive in the coming years in terms of innovative solutions in healthcare.

read more

Radboudumc and Terumo Europe N.V. sign collaboration agreement

3 June 2022

Together, the two partners will improve existing treatments for cancer patients and develop new, personalized therapies. Focus will be on the clinical use of holmium-166 microspheres, small radioactive beads.

read more

More accurate surgery with the Anatomy Projector

30 May 2022

The Anatomy Projector, developed at the Radboudumc, allows surgeons to operate much more accurately with projected augmented reality.

read more

Investment in ARNE helps neonatologists make better decisions when treating newborn babies

28 April 2022

ARNE B.V. has raised financing from Oost NL and venture builder NLC. ARNE supplies smart software with which neonatologists can make decisions based on data after the birth of a child.

read more

Cell4Pharma enters into distribution agreement and strategic partnership with MatTek

25 March 2022

MatTek Life Sciences will distribute Cell4Pharma’s ciPTEC renal cells and utilize the technology in the development of a new in vitro kidney model.

read more